Bernat Olle
Chief Executive Officer Vedanta Biosciences
Dr. Bernat Olle is Founder and Chief Executive Officer of Vedanta Biosciences, where he has pioneered the development of defined bacterial consortia as a new class of oral therapeutics. A recognized leader in the microbiome field, he has co-authored influential research published in leading journals including Nature, JAMA, Nature Medicine, and Nature Biotechnology. Prior to Vedanta, he spent a decade in biotech venture creation at PureTech Health. Dr. Olle has served on multiple boards and advisory committees and has received numerous innovation awards. He holds a B.S., M.S., Ph.D., and M.B.A. from leading institutions including MIT and MIT Sloan.
Seminars
Wednesday 11th November 2026
Panel Discussion: Defining Clear Regulatory & Scientific Boundaries Between Consumer & Live Biotherapeutics to Strengthen Investment Confidence
9:00 am
- Differentiating regulatory pathways for direct-to-consumer probiotics versus IND-driven live biotherapeutics to align development strategies with approval expectations
- Evaluating how inconsistent product claims and low-quality evidence create skepticism, reducing investor confidence and complicating partnership decision-making
- Establishing clear scientific, clinical, and quality benchmarks to distinguish credible therapeutics from underpowered products and enable stronger commercial positioning
